Myriad Genetics Well-Positioned to Outperform and 2 Stock Analyses Making Rounds

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Fidelity National Information Services, Inc. (NYSE:FIS) reported a sales surge of 30 percent year-over-year, Stephens thinks that the increase will likely lower investors’ concerns regarding the company’s sales momentum. The firm recommends purchasing the stock, and it keeps Overweight rating and its $41 target on the stock.

Myriad Genetics Inc. (NASDAQ:MYGN) is believed by Cowen to be in an ideal position to outperform after its Q1 results due to strong organic growth outlook, potential for earnings upside, returns profile, and elimination of near-term reimbursement overhangs. Shares have an Outperform rating.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Farmer Brothers Co. (NASDAQ:FARM) target has been raised by Roth Capital after it reported higher Q1 EPS than predicted. The firm believes that the company’s earnings will show a significant increase over the next couple of years, and it keeps its Buy rating on the stock.

Don’t Miss: Is the U.K. a Tech Company Tax Haven?


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business